+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
KABRADG KABRADG

Kabra Drugs Share Price

₹25.02 +1.34 (5.66%)
29.56% Fall from 52W High

12 Aug, 2026 4:01 PM (IST)

Kabra Drugs live price: ₹25.02. It opened at ₹24 vs previous close ₹24; intraday high/low: ₹26/₹24. The 50 & 200 DMA stand at ₹23.80/₹23.80.

Kabra Drugs Performance

  • Today's Low
  • ₹24
  • Today's High
  • ₹26
  • 52 Week Low
  • ₹16
  • 52 Week High
  • ₹36
  • Open Price₹24
  • Previous Close₹24
  • Volume219,794
  • 50 DMA₹23.80
  • 100 DMA₹24.40
  • 200 DMA₹23.80

Kabra Drugs Chart

Investment Returns

  • Over 1 Month + 15.3%
  • Over 3 Month -6.57%
  • Over 6 Month -26.26%
  • Over 1 Year + 19.2%

Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!

Invest Now

Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 7.8
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 59
  • P/B Ratio
  • 2
  • Average True Range
  • 1.7
  • EPS
  • 3.2
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.3
  • RSI
  • 59.69
  • MFI
  • 75.38

Latest Stock News Updates

Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Resignation of Director

Resignation of director of Ms. Anand Anitha

Kabra Drugs Ltd - 524322 - Undertaking For Non- Applicability Of Regulation 32 Of SEBI

Undertaking for Non-Applicability of Reg 32

Kabra Drugs Ltd - 524322 - Undertaking For Non- Applicability Of Regulation 32 Of SEBI

Undertaking for Non-Applicability of Reg 32

Kabra Drugs Financials

Kabra Drugs Technicals

EMA & SMA

Current Price
₹25.02
+ 1.34 (5.66%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹23.80
  • 50 Day
  • ₹23.80
  • 100 Day
  • ₹24.40
  • 200 Day
  • ₹23.80

Resistance and Support

25.07 Pivot Speed
  • R3 28.30
  • R2 27.30
  • R1 26.10
  • S1 24.00
  • S2 22.90
  • S3 21.80

Kabra Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-12 Quarterly Results
2026-05-29 Quarterly Results
2026-05-06 Others Inter-alia, to consider 1. Pharmaceutical manufacturing & marketing expansion of own brands. 2. Defense & AI Integration: To evaluate opportunities in defense manufacturing. 3. Other business matters.
2026-04-21 Others Inter-alia, to consider 1. Appointment of Ms. Monam Kapoor as Additional Director. 2. Board will discuss the amendment of the Main Objects clause of the MOA. 3. Notice of POM. 4.Other business matters
2026-03-07 Others Inter-alia, to consider 1. Proposal for changing the name of the company. 2. Strategic expansion of business operations in Indonesia and Canada. 3. Other business matters.

Kabra Drugs Shareholding Pattern

100%
0%
0%

Kabra Drugs FAQs

Kabra Drugs share price is ₹25 As on 12 August, 2026 | 23:21

The Market Cap of Kabra Drugs is ₹59.3 Cr As on 12 August, 2026 | 23:21

The P/E ratio of Kabra Drugs is 7.8 As on 12 August, 2026 | 23:21

The PB ratio of Kabra Drugs is 2 As on 12 August, 2026 | 23:21

The 52 week High & Low of Kabra Drugs is ₹35.5/₹15.5 respectively As on 12 August, 2026 | 23:21

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23